Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

INOVIO PHARMACEUTICALS, INC. Director's Dealing 2021

May 17, 2021

34008_dirs_2021-05-17_3b56793e-81a0-474b-92f1-df2f25c9ad26.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: INOVIO PHARMACEUTICALS, INC. (INO)
CIK: 0001055726
Period of Report: 2021-05-13

Reporting Person: DANSEY ROGER D (Director)

More from INOVIO PHARMACEUTICALS, INC.

Regulatory Filings 2026
May 22
Regulatory Filings 2026
May 20
Interim / Quarterly Report 2026
May 13
Regulatory Filings 2026
Apr 6
Regulatory Filings 2026
Apr 2
Director's Dealing 2026
Feb 27
Director's Dealing 2026
Feb 27
Director's Dealing 2026
Feb 27
Director's Dealing 2026
Feb 27
Director's Dealing 2026
Feb 27
View all filings →